AIIMS Anticoagulant icon

1.0.0 by AIIMS, New Delhi


Jan 21, 2020

About AIIMS Anticoagulant

The Anticoagulant App is a pioneering patient support initiative by AIIMS .

The Anticoagulant App is a module prepared to assist the Patient and

Medical Professional in monitoring and maintaining therapeutic profile of

patients on life-long anticoagulant medicines. Special care is required when

receiving these medications as it can lead to complications (stroke/

bleeding) if not administered under medical supervision.

The anticoagulant App is a pioneering patient support initiative created

by Nursing Informatics, Computer Facility and Department of Cardiology,

All India Institute of Medical Sciences (AIIMS). This APP is for in-patient

and out- patients receiving anticoagulants under AIIMS supervision, point

of care INR monitoring resulting in better patient outcomes and improved

compliance.

This APP will help maintain patient PT /INR records in real time and can be

updated remotely by patients from their homes. Self-care instructions are

also available in both English and Hindi for the patients review.

The application is a clinical decision support tool designed to guide

clinicians as they make decisions about prescribing anticoagulants for each

patient under their care.

What's New in the Latest Version 1.0.0

Last updated on Jan 21, 2020

First version.

Translation Loading...

Additional APP Information

Latest Version

Request AIIMS Anticoagulant Update 1.0.0

Uploaded by

Frank Perry

Requires Android

Android 4.2+

Available on

Get AIIMS Anticoagulant on Google Play

Show More

AIIMS Anticoagulant Screenshots

Comment Loading...
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.